TEVA · earnings call history
Teva Q2 FY26 — Strong Innovative Portfolio Drives Growth and Margin Expansion
Read the briefTeva Q1 FY26 — Strong Innovative Portfolio Growth and Strategic Emalex Acquisition
Read the briefTeva Q4 FY25 — Strong Innovative Portfolio Growth and Pipeline Progress
Read the briefTeva Q3 FY25 — Strong Innovative Portfolio Drives 11th Consecutive Quarter of Growth
Read the briefTeva Pharmaceutical Industries Limited Q2 FY25 — Innovative Portfolio Drives 10th Consecutive Quarter of Growth
Read the briefBrowse all US companies on the earnings-call register.